7/5/2017: TransMed7 receives Notice of Allowance from the USPTO for Patent Application 13/853,806 for SpeedBird Soft Tissue Biopsy Platform Technology.
7/1/2017: Dr. Edgar D. Staren joins TransMed7 as President of the company. Dr. Staren also joins as President of Martinet Medical, LLC a subsidiary Project Company of TransMed7 focused on the development of a novel whole-lumpectomy technology platform medical device.
3/26-3/30, 2017: TransMed7 highlights its SpeedBird, Martinet and Cardinal technologies at the annual meeting of the American Society of Breast Surgeons (ASBrS) in Las Vegas.
2/22/2017: TransMed7 receives Notice of Issuance for US Patent No. 9,592,035 for SpeedBird soft tissue biopsy platform technology. The patent will be issued on March 14, 2017.